WULANDARI HARAHAP, P.; PUTRA TARIGAN, S.; NOVISARI SOEROSO, N. Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity. International Journal of Health and Pharmaceutical (IJHP), [S. l.], v. 5, n. 3, p. 422–429, 2025. DOI: 10.51601/ijhp.v5i3.429. Disponível em: https://ijhp.net/index.php/IJHP/article/view/429. Acesso em: 27 sep. 2025.